Navigation Links
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Date:11/5/2011

THOUSAND OAKS, Calif., Nov. 5, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced positive data from the first three years of the open-label extension study of the pivotal Phase 3 fracture trial showing that six years of Prolia® (denosumab) treatment in postmenopausal women with osteoporosis was associated with continued increase in bone mineral density (BMD) and consistent reduction in markers of bone turnover. These results will be presented on Nov. 8, 2011, at the 2011 American College of Rheumatology Annual Scientific Meeting in Chicago.

Results of the open-label extension study showed that postmenopausal women with osteoporosis who received up to six years of continued Prolia treatment experienced cumulative gains of 15.2 percent at the lumbar spine and 7.5 percent at the total hip compared with baseline. The overall adverse event profile is consistent with events previously reported.

"These data are consistent with the pivotal Phase 3 fracture study, which first established the efficacy and safety of Prolia in women with postmenopausal osteoporosis at high risk for fractures," said study author Jacques Brown, M.D., CHUQ-CHUL Research Centre, Laval University. "This study provides further evidence of Prolia's long-term clinical potential for women with this chronic disease."

The FREEDOM Study and the 6-Year Prolia Data

The pivotal Phase 3 fracture trial was based on three years of data from approximately 7,800 postmenopausal women. The open-label study extension is evaluating the long-term (up to 10 years) efficacy and safety of Prolia in 4,550 postmenopausal women. Seventy percent of eligible women from the pivotal Phase 3 fracture study enrolled in the study extension; 2,343 women continued to receive Prolia treatment (long-term group), and 2,207 transitioned from placebo to Prolia (cross-over group).

The long-te
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
2. Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
3. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
4. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
5. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
6. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
7. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
8. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
9. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
10. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
11. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015 ... announced that its shareholders have approved Mylan,s proposed ... ; TASE) and the related issuance of Mylan ... general meeting of shareholders held today. The transaction ... the extraordinary general meeting. In addition, the transaction ...
(Date:8/28/2015)... y LONDRES, 28 de agosto de 2015 /PRNewswire/ ... hoy su participación en el  Congreso de la ... cardiológicas más recientes y novedosas, entre ellas HeartModel ... a las personas y la tecnología con los ... diagnosticar, guiar los tratamientos y permitir atención en ...
(Date:8/27/2015)... 27, 2015  The Academy of Managed Care ... Administration,s (FDA,s) draft guidance and proposed rule that ... to bear a nonproprietary name with an FDA-designated ... a decision from the FDA on the naming ... stakeholders urging the agency to use the same ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... Norway, Feb. 4, 2011 Photocure (OSE: PHO), a ... today announced positive results from its consumer trial with ... skin,s appearance. The RevitAll study was ... confirm if treatment with Allumera™ improves skin appearance, when ...
... Health Corp. (Nasdaq: WBMD ) today announced that ... the UBS 21st Annual Global Healthcare Services Conference on Tuesday, ... analysts and the general public are invited to listen to ...  The broadcast can be accessed at www.wbmd.com (in ...
Cached Medicine Technology:Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 2Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 3Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 4
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor Day ... astronomically, officially ends on September 22nd this year). For IT security personnel, it should ... on which could prove far more costly than a simple headache. , Joe Caruso, ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... the localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also ... shown through research to improve treatment outcomes. This localized treatment seems to ...
(Date:8/28/2015)... ... August 29, 2015 , ... Rio Salado College joined nine educational ... as part of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator ... third Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which is designed ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists are ... children helping children, a thank you to the many creative and generous ways ... the United Methodist initiative to end malaria deaths. , The Columbus Zoo and ...
(Date:8/28/2015)... ... 28, 2015 , ... With the goal of furthering music education programs in ... the Adams County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again ... education in the underfunded school districts of Mendon and its neighboring town of Quincy, ...
Breaking Medicine News(10 mins):Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2
... examined by,the same doctor during their first six ... preventive health screenings -- for lead poisoning,anemia and ... being,cared for repeatedly by the same physician, often ... important factor in the children they studied., ...
... potential diagnostic test that could help surgeons confirm or ... joints that require surgical revision has been developed by ... and Skin Diseases (NIAMS), a part of the National ... a subgroup of people who need the surgery a ...
... 3 ,Comprehensive Pharmacy Services (CPS) with the Commonwealth ... Pharmacy,Services (SOPS) are pleased to announce their new ... of-the-art pharmacy services for all,SOPS customers within participating ... its current vendor due to a number of ...
... Spine Care Centers ... of Excellence, ... Inc. have joined forces to conduct the nation,s first,comprehensive survey of ... spine centers across the nation and uncover,spine care program trends., ...
... for Medical Professionals, NEW YORK, March 3 ... practical knowledge and authority of the,American College of ... a new co-publishing agreement. Through the agreement,McGraw-Hill and ... focused on key,clinical issues and procedures, with an ...
... hosting its Fourth International Research Conference at the ... Baltimore, Md. March 17-18. The two-day conference will ... malaria research, including discussions of malaria parasite genetics ... Nearly half-a-billion people worldwide are infected with malaria. ...
Cached Medicine News:Health News:In Early Childhood, Continuous Care by One Doctor Improves Delivery of Health Screenings 2Health News:In Early Childhood, Continuous Care by One Doctor Improves Delivery of Health Screenings 3Health News:New test for joint infection could spare some patients an unnecessary procedure 2Health News:New test for joint infection could spare some patients an unnecessary procedure 3Health News:Comprehensive Pharmacy Services Awarded $80 Million Dollar Pharmacy Services Contract for the State of Massachusetts 2Health News:Comprehensive Pharmacy Services Awarded $80 Million Dollar Pharmacy Services Contract for the State of Massachusetts 3Health News:SpineMark, NeuStrategy Partner to Conduct Nation's First Spine COE Survey(TM) 2Health News:SpineMark, NeuStrategy Partner to Conduct Nation's First Spine COE Survey(TM) 3Health News:McGraw-Hill Professional Enters Partnership with American College of Physicians, the World's Largest Internal Medicine Organization 2
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Wide 1 mm x 3 mm smooth platform. Serrated handle with polished finish. Most popular size or model....
Oval solid 15 mm wide lower plate. Open upper plate with inside dimensions 11 mm x 8 mm. Serrated handle with locking thumb screw and polished finish....
Fine 2 mm wide platform. Cross action serrated handle with metal tip guard. Polished finish....
Medicine Products: